Skip to main content

Research

News

Faecal microbiota transplantation: indications, evidence and safety

Posted: March 4 2021

Read the full article in Australian Prescriber. Listen to podcast here. Transcript Welcome to Australian Prescriber Podcast. Australian Prescriber, independent, peer-reviewed, and free. Faecal microbiota transplantation or FMT. At first, it evoked surprise and mirth among some, but that was quickly replaced by the excitement about the possibilities that FMT might bring. It suddenly escalated as a potential […]

Read more

News

Crohn’s disease in Australia – the latest research

Posted: March 2 2021

Research Scientist and Paediatric Gastroenterologist Dr Ed Giles and Associate Professor Rebecca Lim are both leading research into Crohn’s at Hudson Institute. Dr Ed Giles is leading two Crohn’s studies at Hudson Institute. One is investigating the relationship between the microbiome and Crohn’s. The other is examining our immune system response and its relationship to inflammation […]

Read more

Research

Greenspace exposure during childhood reduces risk for IBD

Childhood exposure to residential greenspace was associated with a reduced risk for inflammatory bowel disease, according to data published in the American Journal of Gastroenterology.

By Monica Stonehill “Intervention studies designed to target specific environmental risk factors to reduce the risk of IBD should include greenspace in study design,” Michael Elten, MSc, from the School of Epidemiology and Public Health, University of Ottawa in Canada, and colleagues wrote. “It is possible that by changing our immediate environment, we could prevent childhood-onset IBD.” Elten and colleagues […]

Read more

News

New potential therapy for Crohn’s disease in children

Posted: February 24 2021

Scientists from the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago demonstrated that a nanotherapy reduces intestinal inflammation and shrinks lesions in a rodent model of severe Crohn’s disease. This approach could become an alternative to biologic antibody therapies that carry many side effects, including increased risk of certain cancers. […]

Read more

News

Fungi in the gut prime immunity against infection

Posted: February 12 2021

Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine. Breakdowns in this process can leave people susceptible to deadly fungal infections. The study, published Feb. 5 in Cell, reveals a new twist in the complex relationship […]

Read more

News

Study identifies ‘Achilles heel’ of bacteria linked to Crohn’s disease

Posted: February 11 2021

In a study published Feb. 3 in Cell Host and Microbe, the investigators showed that patients with Crohn’s disease have an overabundance of a type of gut bacteria called adherent-invasive Escherichia coli (AIEC), whichpromotes inflammation in the intestine. Their experiments revealed that a metabolite produced by the bacteria interacts with immune system cells in the lining of […]

Read more

News

Scientists switch on tissue repair in inflammatory bowel disease

Posted: February 9 2021

When functioning correctly, the immune system protects against harmful agents such as bacteria that get into the body. But in conditions such as inflammatory bowel disease (IBD), the immune system attacks the tissues that line the gut, forming ulcers and causing pain and discomfort. Nearly 3.9 million women and 3.0 million men are living with […]

Read more

Research

International perspectives on management of inflammatory bowel disease

Opinion differences and similarities between patients and physicians from the IBD GAPPS Survey.

Abstract Background Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis (UC), are complex disorders with multiple comorbidities. We conducted international patient and physician surveys to evaluate current experiences and perceptions of patients with CD or UC and physicians who treat IBD. Methods The IBD Global Assessment of Patient and Physician Unmet Need […]

Read more

Research

Ulcerative colitis narrative global survey findings

The impact of living with ulcerative colitis—patients’ and physicians’ views.

Abstract Background The Ulcerative Colitis (UC) Narrative is a global patient and physician survey aimed at identifying the impact of UC and comparing and contrasting perceptions of UC burden and management approaches. Methods Surveys of patients with UC (self-reported diagnosis; n = 2100) and physicians (n = 1254) were completed across 10 countries by The […]

Read more

News

‘Creeping Fat’ in Crohn’s patients linked to bacteria

Posted: February 5 2021

In many patients with Crohn’s disease abdominal fat migrates to the wall of the inflamed small intestines. What prompts the fat tissue to “creep” through the abdomen and wrap around the intestines of many patients with this inflammatory bowel disease (IBD) has been an enduring mystery. Now, investigators have identified a critical clue. In a study […]

Read more